Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Upcoming SAA research: cyclosporine and eltrombopag

Carlo Dufour • 26 Oct 2019
COSTEM 2019
Anemias Aplastic Anemia Cyclosporine Eltrombopag

Carlo Dufour, MD, Giannina Gaslini Institute, Genoa, Italy, discusses the rapid pace of research in severe aplastic anemia (SAA). This interview took place at the 5th International Congress on Controversies inStem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Carlo Dufour

2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
4:55
New guidelines for the management of neutropenia & challenges in this space
Carlo Dufour • 23 Apr 2023
2:17
BMF diagnosis with NGS and gene panels
Carlo Dufour • 1 Sep 2020

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
3:45
A two-year analysis of the EBMT-SAAWP RACE trial: eltrombopag in aplastic anemia
Antonio Risitano • 16 Apr 2024
1:31
Mitapivat improves work/school attendance in patients with pyruvate kinase deficiency
Hanny Al-Samkari • 9 Dec 2023
2:13
SATISFY: mitapivat in patients with erythrocyte membranopathies
Kevin Kuo • 10 Dec 2023
The content of VJHemOnc is intended for healthcare professionals